-

Scott+Scott Attorneys at Law LLP Investigates Mudrick Capital Acquisition Corporation’s Directors and Officers for Breach of Fiduciary Duties – MUDS, HYMC

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether certain directors and officers of Mudrick Capital Acquisition Corporation (“Mudrick Capital”) (NASDAQ: MUDS), now known as Hycroft Mining Holding Corporation (“Hycroft”) (NASDAQ: HYMC), breached their fiduciary duties to Mudrick Capital and its shareholders. If you were a Mudrick Capital shareholder, you may contact attorney Joe Pettigrew for additional information toll-free at 844-818-6982 or jpettigrew@scott-scott.com.

Scott+Scott is investigating whether Mudrick Capital’s board of directors or senior management failed to manage Mudrick Capital in an acceptable manner, in breach of their fiduciary duties to Mudrick Capital shareholders, and whether Mudrick Capital’s shareholders suffered damages as a result.

On January 13, 2020, Mudrick Capital executed a merger agreement with the predecessor to Hycroft, with an April 17, 2020 record date for the shareholder vote. On May 29, 2020, the merger transaction closed, with Hycroft continuing as the successor entity.

On October 1, 2020, Hycroft announced a secondary offering, ultimately consisting of 9.5 million shares of common stock and the same number of immediately exercisable warrants, bringing net proceeds of $83.1 million. On this news, shares dropped 16% to $7.58/share. On March 24, 2021, Hycroft announced financial results for 2020 and the financial outlook for 2021. On this news, shares dropped over 28% to $4.96.

What You Can Do

If you were a Mudrick Capital shareholder, you may have legal claims against Mudrick Capital’s directors and officers. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew toll-free at 844-818-6982 or jpettigrew@scott-scott.com.

About Scott+Scott

Scott+Scott has significant experience in prosecuting major securities, antitrust, and consumer rights actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Amsterdam, Connecticut, California, Virginia, and Ohio.

Attorney Advertising

Contacts

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
230 Park Avenue, 17th Floor, New York, NY 10169
844-818-6982
jpettigrew@scott-scott.com

Scott+Scott Attorneys at Law LLP

NASDAQ:HYMC

Release Summary
Scott+Scott Attorneys at Law LLP Investigates Mudrick Capital Acquisition Corp.’s Directors and Officers for Breach of Fiduciary Duties – MUDS, HYMC
Release Versions

Contacts

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
230 Park Avenue, 17th Floor, New York, NY 10169
844-818-6982
jpettigrew@scott-scott.com

More News From Scott+Scott Attorneys at Law LLP

CELSIUS HOLDINGS, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Celsius Holdings, Inc.’s Directors and Officers for Breach of Fiduciary Duties – CELH

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Celsius Holdings, Inc. (NASDAQ: CELH) failed to manage Celsius in an acceptable manner, breaching their fiduciary duties to Celsius, and whether Celsius and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know:On June 4, 2026, the Office of the Texas Attorney General...

ADMA BIOLOGICS, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates ADMA Biologics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – ADMA

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) failed to manage ADMA Biologics in an acceptable manner, breaching their fiduciary duties to ADMA Biologics, and whether ADMA Biologics and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know:On March 24, 2026, Culper Research publ...

THE ENSIGN GROUP, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates The Ensign Group, Inc.’s Directors and Officers for Breach of Fiduciary Duties – ENSG

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of The Ensign Group, Inc. (NASDAQ: ENSG) failed to manage The Ensign Group in an acceptable manner, breaching their fiduciary duties to Ensign Group, and whether Ensign Group and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know:On June 11, 2026, Muddy Waters Research...
Back to Newsroom